These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 1500527)

  • 1. Presence of specific immunoglobulin A-secreting cells in peripheral blood after natural infection with Shigella sonnei.
    Orr N; Robin G; Lowell G; Cohen D
    J Clin Microbiol; 1992 Aug; 30(8):2165-8. PubMed ID: 1500527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of antibodies to Shigella lipopolysaccharide in urine after natural Shigella infection or vaccination.
    Cohen D; Orr N; Robin G; Slepon R; Ashkenazi S; Ashkenazi I; Shemer J
    Clin Diagn Lab Immunol; 1996 Jul; 3(4):451-5. PubMed ID: 8807212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Shigella lipopolysaccharide antibodies in pediatric populations.
    Passwell JH; Freier S; Shor R; Farzam N; Block C; Lison M; Shiff E; Ashkenazi S
    Pediatr Infect Dis J; 1995 Oct; 14(10):859-65. PubMed ID: 8584312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Shigella-specific antibodies in the first year of life among Zambian infants: A longitudinal cohort study.
    Chisenga CC; Bosomprah S; Simuyandi M; Mwila-Kazimbaya K; Chilyabanyama ON; Laban NM; Bialik A; Asato V; Meron-Sudai S; Frankel G; Cohen D; Chilengi R
    PLoS One; 2021; 16(5):e0252222. PubMed ID: 34043697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody in Lymphocyte Supernatant (ALS) responses after oral vaccination with live Shigella sonnei vaccine candidates WRSs2 and WRSs3 and correlation with serum antibodies, ASCs, fecal IgA and shedding.
    Venkatesan MM; Ballou C; Barnoy S; McNeal M; El-Khorazaty J; Frenck R; Baqar S
    PLoS One; 2021; 16(11):e0259361. PubMed ID: 34793505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative analysis of IgG class and subclass and IgA serum response to Shigella sonnei and Shigella flexneri 2a polysaccharides following vaccination with Shigella conjugate vaccines.
    Robin G; Keisari Y; Slepon R; Ashkenazi S; Cohen D
    Vaccine; 1999 Aug; 17(23-24):3109-15. PubMed ID: 10462247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization and quantitative analysis of serum IgG class and subclass response to Shigella sonnei and Shigella flexneri 2a lipopolysaccharide following natural Shigella infection.
    Robin G; Cohen D; Orr N; Markus I; Slepon R; Ashkenazi S; Keisari Y
    J Infect Dis; 1997 May; 175(5):1128-33. PubMed ID: 9129076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune Response Characterization after Controlled Infection with Lyophilized Shigella sonnei 53G.
    Clarkson KA; Frenck RW; Dickey M; Suvarnapunya AE; Chandrasekaran L; Weerts HP; Heaney CD; McNeal M; Detizio K; Parker S; Hoeper A; Bourgeois AL; Porter CK; Venkatesan MM; Kaminski RW
    mSphere; 2020 Sep; 5(5):. PubMed ID: 32968012
    [No Abstract]   [Full Text] [Related]  

  • 9. Predominance of serotype-specific mucosal antibody response in Shigella flexneri-infected humans living in an area of endemicity.
    Rasolofo-Razanamparany V; Cassel-Beraud AM; Roux J; Sansonetti PJ; Phalipon A
    Infect Immun; 2001 Sep; 69(9):5230-4. PubMed ID: 11500390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [An immunoenzyme method for determining IgA antibodies to lipopolysaccharide in secretions in the diagnosis of shigellosis].
    Salamatova SA; Sukhoroslova LI; Shalamberidze IA; Brusenina ND
    Zh Mikrobiol Epidemiol Immunobiol; 1993; (3):85-9. PubMed ID: 8067099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and immunogenicity of Shigella sonnei-CRM9 and Shigella flexneri type 2a-rEPAsucc conjugate vaccines in one- to four-year-old children.
    Passwell JH; Ashkenazi S; Harlev E; Miron D; Ramon R; Farzam N; Lerner-Geva L; Levi Y; Chu C; Shiloach J; Robbins JB; Schneerson R;
    Pediatr Infect Dis J; 2003 Aug; 22(8):701-6. PubMed ID: 12913770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development, Interlaboratory Evaluations, and Application of a Simple, High-Throughput
    Nahm MH; Yu J; Weerts HP; Wenzel H; Tamilselvi CS; Chandrasekaran L; Pasetti MF; Mani S; Kaminski RW
    mSphere; 2018 Jun; 3(3):. PubMed ID: 29898979
    [No Abstract]   [Full Text] [Related]  

  • 13. Concentration of milk secretory immunoglobulin A against Shigella virulence plasmid-associated antigens as a predictor of symptom status in Shigella-infected breast-fed infants.
    Hayani KC; Guerrero ML; Morrow AL; Gomez HF; Winsor DK; Ruiz-Palacios GM; Cleary TG
    J Pediatr; 1992 Dec; 121(6):852-6. PubMed ID: 1447644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and immunogenicity of Shigella sonnei and Shigella flexneri 2a O-specific polysaccharide conjugates in children.
    Ashkenazi S; Passwell JH; Harlev E; Miron D; Dagan R; Farzan N; Ramon R; Majadly F; Bryla DA; Karpas AB; Robbins JB; Schneerson R
    J Infect Dis; 1999 Jun; 179(6):1565-8. PubMed ID: 10228084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics of Shigella sonnei infection of volunteers: signs, symptoms, immune responses, changes in selected cytokines and acute-phase substances.
    Munoz C; Baqar S; van de Verg L; Thupari J; Goldblum S; Olson JG; Taylor DN; Heresi GP; Murphy JR
    Am J Trop Med Hyg; 1995 Jul; 53(1):47-54. PubMed ID: 7542845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum antibody responses against shigella lipopolysaccharides and invasion plasmid-coded antigens in shigella infected Swedish patients.
    Li A; Rong ZC; Ekwall E; Forsum U; Lindberg AA
    Scand J Infect Dis; 1993; 25(5):569-77. PubMed ID: 8284641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The determination in saliva of IgA antibodies to Shigella ribosomes for the diagnosis of dysentery].
    Salamatova SA; Sukhoroslova LI; Chernokhvostova EV; Levenson VI
    Zh Mikrobiol Epidemiol Immunobiol; 1991 Jun; (6):59-62. PubMed ID: 1887713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific immunoglobulin A-secreting cells in peripheral blood of humans following oral immunization with a bivalent Salmonella typhi-Shigella sonnei vaccine or infection by pathogenic S. sonnei.
    Van de Verg L; Herrington DA; Murphy JR; Wasserman SS; Formal SB; Levine MM
    Infect Immun; 1990 Jun; 58(6):2002-4. PubMed ID: 1692813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody response to Shigella sonnei infection determined by an enzyme-linked immunosorbent assay.
    Ekwall E; Haeggmann S; Kalin M; Svenungsson B; Lindberg AA
    Eur J Clin Microbiol; 1983 Jun; 2(3):200-5. PubMed ID: 6349988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sociodemographic factors associated with serum anti-Shigella lipopolysaccharide antibodies and shigellosis.
    Cohen D; Slepon R; Green MS
    Int J Epidemiol; 1991 Jun; 20(2):546-50. PubMed ID: 1917263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.